Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

In this issue

Insight

Illustration of asthma, inhaler, lungs and pills

Dangers with inappropriate use of long-acting beta agonists Subscription

By , ,

Caution is required when prescribing or dispensing long-acting beta agonists to manage airways diseases, such as asthma.

Perspective article

Scanning electron micrograph (SEM) of a lymphocyte with HIV cluster

Pre-exposure prophylaxis should be a key component of a comprehensive HIV prevention package fully funded on the NHSSubscription

By

Pre-exposure prophylaxis (PrEP) is the medication taken by HIV-negative individuals to reduce their risk of contracting HIV infection. The large evidence base for the use of PrEP has been reviewed and recommended by the World Health Organization (WHO), a specialised agency of the United Nations that is concerned with international public health, the Joint United Nations Programme on HIV and AIDS (UNAIDS) and the National Institute for Health and Care Excellence (NICE), England’s health ...

Review

Geneticist at the French National Institute for Health and Medical Research (Inserm) researches genetic diseases like cystic fibrosis

Conventional therapies and emergent precision medicines for cystic fibrosis: challenges and opportunitiesSubscription

By

Around 27 years ago, the discovery of the cystic fibrosis transmembrane conductance regulator (CFTR) gene – responsible for causing cystic fibrosis (CF) – marked a significant moment in the history of the condition. Despite the early promise of this target for gene therapy, a universally successful treatment has proven elusive in the ensuing years. While clinical trials involving gene therapy continue to make progress, the ‘magic bullet’ remains some way off. Survival continues to ...

Short communications

Child obesity rates continue to grow in England — we need action nowSubscription

By

In October 2016, NHS Digital released the latest set of figures from the National Child Measurement Programme (NCMP). Another set of childhood obesity statistics and another bleak picture. Year on year, we are faced with sobering figures that reveal an increasingly worrying trend: the number of obese and overweight children in the UK is not falling and is, in fact, rising.

Promoting self care to reduce unnecessary GP visits

By

Healthcare is changing dramatically and so are the needs of our patients. As such, GPs and our teams are changing the ways in which we are working, but we also need our patients to play their part.

Researchers wanted Subscription

By

We are looking for researchers who are working on medicines supply and shortages of medicines to join a network of researchers in the UK and other European countries so that they can meet and share their knowledge. Financial support is available for travel and accommodation to workshops and conferences and grants are available towards attendance at training schools and short-term scientific missions (exchange visits of a few days). In particular, we are looking for “early career investigators”,

Spotting the signs of oral mouth cancer in pharmacySubscription

By

In the UK, mouth cancer cases have increased by 39% in the past decade and by 92% since the 1970s. In fact, it is one of a small number of cancers that is continuing to see cases increase. Alongside this, survival rates have not improved in the same period and, sadly, more than 2,000 lives are lost to the disease every year. This is twice as many as cervical and testicular cancers combined and much of this can be attributed to late diagnosis.

Pharmaceutical Journal Jobs

More jobs

Clinical Pharmacist

CP December 2016, Vol 8, No 12

Cover Story:

PrEP should be fully funded by the NHS to prevent HIV

Read more…

Clinical Pharmacist

View previous issue

Clinical Pharmacist is a monthly, peer-reviewed journal that provides authoritative resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development. Clinical Pharmacist publishes Review articles, Perspectives, evidence-based CPD articles and Research articles on topics from drug discovery to clinical pharmacology and pharmacy.

The international audience of Pharmaceutical Journal Publications consists of pharmacists, pharmaceutical scientists and healthcare professionals. The journal is available to 44,000 members of the Royal Pharmaceutical Society, as well as non-member individual subscribers and subscribing institutions.